American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
+$472M |
| 2 |
Amazon
AMZN
|
+$397M |
| 3 |
Pfizer
PFE
|
+$189M |
| 4 |
EQT Corp
EQT
|
+$112M |
| 5 |
Zimmer Biomet
ZBH
|
+$103M |
Top Sells
| 1 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$293M |
| 2 |
Intuit
INTU
|
+$168M |
| 3 |
TW
TOWERS WATSON & CO COM STK CL A (DE)
TW
|
+$156M |
| 4 |
Humana
HUM
|
+$131M |
| 5 |
Stryker
SYK
|
+$129M |
Sector Composition
| 1 | Healthcare | 13.87% |
| 2 | Financials | 12.96% |
| 3 | Technology | 12.74% |
| 4 | Consumer Discretionary | 11.67% |
| 5 | Industrials | 10.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
iShares MSCI India ETF
INDA
$9.38B
| $236K | ﹤0.01% |
8,261
-400
| -5% | -$11.4K |
|
1302
Visteon
VC
$3.42B
| $234K | ﹤0.01% |
+2,313
| New | +$234K |
|
1303
Bloomin' Brands
BLMN
$586M
| $233K | ﹤0.01% |
+12,805
| New | +$233K |
|
|
EMCI
1304
DELISTED
EMC INS Group Inc
EMCI
| $232K | ﹤0.01% |
+9,990
| New | +$232K |
|
1305
Toyota
TM
$257B
| $231K | ﹤0.01% |
+1,970
| New | +$231K |
|
|
FRP
1306
DELISTED
Fairpoint Communications, Inc.
FRP
| $227K | ﹤0.01% |
+14,723
| New | +$227K |
|
|
VER
1307
DELISTED
VEREIT, Inc.
VER
| $225K | ﹤0.01% |
+5,820
| New | +$225K |
|
1308
TechTarget
TTGT
$404M
| $223K | ﹤0.01% |
+26,227
| New | +$223K |
|
1309
Fluor
FLR
$6.69B
| $221K | ﹤0.01% |
5,229
-91
| -2% | -$3.85K |
|
|
OMN
1310
DELISTED
OMNOVA Solutions Inc.
OMN
| $216K | ﹤0.01% |
+38,963
| New | +$216K |
|
1311
Ryerson Holding
RYI
$707M
| $215K | ﹤0.01% |
+40,905
| New | +$215K |
|
1312
Myriad Genetics
MYGN
$642M
| $213K | ﹤0.01% |
+5,690
| New | +$213K |
|
1313
Cadence Bank
CADE
$6.94B
| $212K | ﹤0.01% |
8,917
-155
| -2% | -$3.69K |
|
1314
Ryder
R
$7.61B
| $203K | ﹤0.01% |
2,737
-47
| -2% | -$3.49K |
|
1315
RB Global
RBA
$21.6B
| $202K | ﹤0.01% |
+7,788
| New | +$202K |
|
|
BCOV
1316
DELISTED
Brightcove, Inc.
BCOV
| $181K | ﹤0.01% |
+36,784
| New | +$181K |
|
|
DNR
1317
DELISTED
Denbury Resources, Inc.
DNR
| $177K | ﹤0.01% |
72,473
-149,243
| -67% | -$364K |
|
|
XCRA
1318
DELISTED
Xcerra Corporation
XCRA
| $175K | ﹤0.01% |
27,895
-17,445
| -38% | -$109K |
|
|
BHR
1319
Braemar Hotels & Resorts
BHR
$199M
| $166K | ﹤0.01% |
11,921
-20,361
| -63% | -$284K |
|
|
TAST
1320
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $161K | ﹤0.01% |
+13,496
| New | +$161K |
|
1321
iShares Silver Trust
SLV
$20.2B
| $147K | ﹤0.01% |
10,629
-3,291
| -24% | -$45.5K |
|
|
RAD
1322
DELISTED
Rite Aid Corporation
RAD
| $120K | ﹤0.01% |
989
-18
| -2% | -$2.18K |
|
1323
Marchex
MCHX
$88.4M
| $118K | ﹤0.01% |
29,279
-10,978
| -27% | -$44.2K |
|
1324
Cytokinetics
CYTK
$6.22B
| $111K | ﹤0.01% |
+16,541
| New | +$111K |
|
|
SRNE
1325
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $111K | ﹤0.01% |
+13,278
| New | +$111K |
|